Resveratrol chemoprotective effect and COX 2 down regulation in tumor suppression in DMBA induced breast cancer in female Sprague Dawley rats


  • Aneena Suresh Department of Pharmacy Practice, JSS College of Pharmacy, Ooty, Tamil Nadu, India
  • Rajat Rana Department of Pharmacy Practice, Asmara College of Health Sciences, Asmara, Eritrea
  • Keerthana C. Department of Pharmacy Practice, JSS College of Pharmacy, Ooty, Tamil Nadu, India



Cox 2, Fibroadenoma, Latency, Resveratrol, Tumor incidence


Background: Aim of the study was to assess the Chemo protective role of Resveratrol in 7,12‑Dimethylbenzanthracene (DMBA) induced breast cancer in Female Sprague Dawley rats and its possible role in down regulation of COX 2, an enzyme known to be expressed in breast cancer tissues.

Methods: A total of 40 female Sprague dawley rats (total 4 groups, n = 10 per group) 6 weeks old, group 1 on pulverized rodent diet, group 2 DMBA with diet, group 3 DMBA and diet with Resveratrol 100mcg, group 4 DMBA and diet with Resveratrol 200mcg. After 120 days experiment was terminated and tumors were analyzed for multiplicity, incidence and histology. Cox 2 expression was analyzed by Western blot analysis. Values were statistically tested using one way variance and Tukey’s comparison test.

Results: Body weight and tumor volume was similar, there was remarkable high latency period for tumor onset and reduction in tumor multiplicity and

incidence in resveratrol treated groups. Tumor incidence was 42.27±10.17 for Group 2, 21.91±5.87 for Group 3, 13.73±3.98 for group 4. Tumor multiplicity was reported as 0.8909±0.30 for group 2, 0.1036±0.04 for group 3, 0.04545±0.02 for group 4. Histopathological analysis revealed ductal carcinoma in group 2, minor tissue necrosis in group 3 and fibroadenoma in group 4.

Conclusions: Resveratrol has chemoprevention action against DMBA induced breast cancer and suppresses COX 2 expression in breast carcinoma.


Waladkhani A, Clemens M. Effect of dietary phytochemicals on cancer development. Bioorg. Med. Chem. Lett. 1998;1:747-53.

Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Malone WA, Boone CW, et al. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J. Nutr. 2000;130:467-71.

Howitz K, Bitterman K, Cohen H. Small molecule activators of sirtuins extend Saccharomyces cerevisiae life span. Nature. 2003;425:191-96.

Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA. 1997;94:14138-43.

Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemo preventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275:218-20.

Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, et al. Resveratrol: a review of pre- clinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007;224:274-83.

Shankar S, Singh G, Srivastava R. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potentials. Front Biosci. 2007;12:4839-54.

Holme A, Pervaiz S. Resveratrolin cell fate decisions. J Bioenerg Biomembr. 2007;39:59-63.

King R, Bomser J, Min D. Bioactivity of resveratrol. Compreh Rev Food Sci Food Safety. 2006;5:65-70.

Whitsett T, Carpenter M, Lamartiniere CA. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J Carcinog. 2006;5:1

De Martin R, Schmid J, Hofer R. The NF-B/Rel family of transcription factors in oncogenic transformation and apoptosis. Mutat. Res. 1999;437:231-43.

Gilmore TD, Koedood M, Piffat KA, White DW. Rel/NF-B/IB proteins and cancer. Oncogene. 1996;13:1367-78.

Jang M, Pezzuto J. Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett. 1998;134:81-9.

Banerjee S, Ramos C, Aggarwal B. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappa B, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 2002;62:4945-54.

Jang M, Pezzuto J. Cancer chemo preventive activity of resveratrol. Drugs Exp. Clin. Res. 1999;25:65-77.

Hilakivi L. Estrogens, BRCA1 and breast cancer. Cancer Res. 2000;60:4993-01.

Lu R, Serrero G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J. Cell. Physiol. 1999;179:297-04.




How to Cite

Suresh, A., Rana, R., & C., K. (2017). Resveratrol chemoprotective effect and COX 2 down regulation in tumor suppression in DMBA induced breast cancer in female Sprague Dawley rats. International Journal of Basic & Clinical Pharmacology, 6(6), 1517–1521.



Original Research Articles